SoftBank expects $24B in losses from Vision Fund, WeWork and OneWeb

Re:SoftBank expects $24B in losses from Vision Fund, WeWork ... by rubber_duck on Tuesday April 14, 2020 @07:00PM (#22872517)

I have one question related to this - when we are talking these astronomical figures (10s or 100s of billions) - is there actually enough room to create new investment opportunities in such field or would it just bid up the prices on the existing ones and possibly screw up the price/return ratio ?

Biotech does not sound like computer programming - I can't turn my hobby project in to a product or train myself to enter the field in a relatively short amount of time ?

Let's say you redirect a huge amount of money in to biotech startups - are there really that many opportunities waiting to be invested in ? The way I see it is best case scenario is you bid up the market price and drive interest in the industry - but that's going to lag years and there's no reward for the people going in ?

On the other hand real-estate/financial speculation seems almost infinitely scalable in comparison.

[ Parent | on HN ]

Re:SoftBank expects $24B in losses from Vision Fund, WeWork ... by hkmurakami on Tuesday April 14, 2020 @07:23PM (#22872658)

Many biotech startups sell themselves for 8-9 figures before their drugs or therapies reach full market maturity, so that they transfer remaining risks to larger pharma companies. If we quantify the post acquisition capital spend by the big pharma then we can get a picture for what kind of follow on investment market is available.

[ Parent | on HN ]